Symbiotec Pharmalab bulk deals, insider trading and stake changes
NSE: SYMBIOTECBSE: 544889Pharmaceuticals & Biotechnology
Last close ₹1,164.20down ₹33.30 (2.78%)BSE ₹1,164.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,197.50.
Range of traded prices from listing on 1 Sep 2026 to 23 Oct 2026
₹934.20Low, 1 Sep 2026₹1,309.90High, 16 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹7,481 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No balance sheet
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Sep 2026
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,58,23231.5% delivered
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Symbiotec Pharmalab promoter holding
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Others0 purchases, 16 salesNo purchase₹12 CrNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.−₹12 Cr5 pledge filings of unclear kind
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Symbiotec Pharmalab insider trading
All 25 disclosures on record.Insider trading, all companies
Sep 2026
- SALIL JAIN₹0.10 Cr825 sharesSold or invoked · Designated Person · 30 Sep 2026 · disclosed 7 Oct
- DEVENDRA SINGH KUSHWAH₹0.12 Cr1,000 sharesSold · Designated Person · 30 Sep 2026 · disclosed 1 Oct · stake 0.03% before, 0.03% after
- DEEPAK PATEL₹0.24 Cr2,000 sharesSold · Designated Person · 30 Sep 2026 · disclosed 5 Oct · stake 0.05% before, 0.04% after
- NISHIKANT Digambar GHADGE₹0.12 Cr1,000 sharesSold · Designated Person · 30 Sep 2026 · disclosed 1 Oct · stake 0.03% before, 0.03% after
- RAJESH BHIMRAO MESHRAM₹0.81 Cr7,000 sharesSold · Designated Person · 30 Sep 2026 · disclosed 5 Oct · stake 0.02% before, 0.01% after
- SUNIL KUMAR PANDEY₹1.01 Cr8,500 sharesSold · Designated Person · 30 Sep 2026 · disclosed 5 Oct · stake 0.02% before, 0.01% after
- JITENDRA SHARMA₹1.07 Cr9,200 sharesSold · Designated Person · 30 Sep 2026 · disclosed 5 Oct · stake 0.04% before, 0.02% after
- MITESH PATEL₹1.34 Cr11,500 sharesSold · Designated Person · 30 Sep 2026 · disclosed 5 Oct · stake 0.06% before, 0.04% after
- RAMAN PRASAD VERMA₹1.99 Cr17,000 sharesSold · Designated Person · 30 Sep 2026 · disclosed 5 Oct · stake 0.09% before, 0.06% after
- SACHIN MADHUKAR CHAUDHARI₹0.29 Cr2,500 sharesSold · Designated Person · 30 Sep 2026 · disclosed 5 Oct · stake 0.02% before, 0.02% after
- SUMAN PODDER₹1.77 Cr15,000 sharesSold · Designated Person · 30 Sep 2026 · disclosed 5 Oct · stake 0.07% before, 0.05% after
- VIJAY SHARMA₹0.24 Cr2,000 sharesSold · Designated Person · 30 Sep 2026 · disclosed 5 Oct · stake 0.02% before, 0.01% after
- DHARM SHANKER PANDEY₹1.46 Cr12,470 sharesSold · Designated Person · 30 Sep 2026 · disclosed 5 Oct · stake 0.04% before, 0.02% after
- DR.PRATIMA KHATRI₹0.65 Cr5,500 sharesSold · Designated Person · 30 Sep 2026 · disclosed 5 Oct · stake 0.03% before, 0.02% after
- DEEPAK PATEL₹0.32 Cr2,715 sharesSold or invoked · Designated Person · 29 Sep 2026 · disclosed 7 Oct
- NISHIKANT GHADGE₹0.12 Cr1,001 sharesSold or invoked · Designated Person · 29 Sep 2026 · disclosed 7 Oct
- TANMAY SACHDEV₹1.03 Cr9,000 sharesPledge · Designated Person · 29 Sep 2026 · disclosed 7 Oct
- VIVEK ASTHANA₹1.54 Cr13,470 sharesPledge · Designated Person · 29 Sep 2026 · disclosed 7 Oct
- VIVEK ASTHANA₹0.11 Cr1,000 sharesSold · Designated Person · 29 Sep 2026 · disclosed 30 Sep · stake 0.02% before, 0.02% after
- VIVEK ASTHANA₹0.58 Cr5,500 sharesSold · Designated Person · 28 Sep 2026 · disclosed 30 Sep · stake 0.03% before, 0.02% after
- VIJAY SHARMA₹0.33 Cr2,900 sharesSold or invoked · Designated Person · 24 Sep 2026 · disclosed 7 Oct
- VIJAY SHARMA₹0.09 Cr900 sharesSold · Designated Person · 24 Sep 2026 · disclosed 30 Sep · stake 0.02% before, 0.02% after
- RAGHAVENDER RAMACHANDRAN₹3.07 Cr30,000 sharesPledge · Designated Person · 24 Sep 2026 · disclosed 5 Oct
- TANMAY SACHDEV₹0.92 Cr9,000 sharesPledge · Designated Person · 24 Sep 2026 · disclosed 5 Oct
- SALIL JAIN₹0.26 Cr2,500 sharesPledge · Designated Person · 24 Sep 2026 · disclosed 5 Oct
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Symbiotec Pharmalab stake sales and purchases
All 3 disclosures on record.
Sep 2026
- AcquiredBeacon Trusteeship Limited7.38% of the company47,48,208 sharesholds 7.38% after9 Sep 2026 · filed under the 5% rule
- AcquiredBeacon Trusteeship Limited acting in its capacity as the debenture trustee5.44% of the company34,93,464 sharesholds 5.44% after8 Sep 2026 · filed under the 5% rule
- AcquiredMirae Asset Mutual Fund5.44% of the company34,97,420 sharesholds 6.21% after1 Sep 2026 · filed under the 5% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Symbiotec Pharmalab bulk deals
Last 12 months, since 23 Oct 2025: 23 bulk deals, ₹865 Cr bought and ₹821 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Wednesday 2 Sep 20261 firm · ₹40 Cr bought · ₹40 Cr soldNet sold ₹0.01 Cr
- Both waysJUNOMONETA FINSOL PRIVATE LIMITEDBought 3,57,516 at ₹1,123.40Sold 3,57,516 at ₹1,123.680.56% of the companyNet nil₹40 Cr bought
Tuesday 1 Sep 202610 firms · ₹824 Cr bought · ₹781 Cr soldNet bought ₹43 Cr
- BoughtTIMF HOLDINGSBought 3,77,247 at ₹989.200.59% of the company₹37 Cr
- Both waysJUNOMONETA FINSOL PRIVATE LIMITEDBought 18,76,359 at ₹1,068.22Sold 18,47,308 at ₹1,066.892.92% of the companyNet +29,051 shares₹200 Cr bought
- Both waysYUGA STOCKS AND COMMODITIES PRIVATE LIMITEDBought 4,71,917 at ₹1,051.46Sold 4,46,917 at ₹1,057.630.73% of the companyNet +25,000 shares₹50 Cr bought
- Both waysELIXIR WEALTH MANAGEMENT PRIVATE LIMITEDBought 5,52,698 at ₹1,074.10Sold 5,47,601 at ₹1,074.040.86% of the companyNet +5,097 shares₹59 Cr bought
- Both waysIRAGE BROKING SERVICES LLPBought 13,46,601 at ₹1,068.39Sold 13,46,601 at ₹1,069.792.10% of the companyNet nil₹144 Cr bought
- Both waysGOLDMINE STOCKS PRIVATE LIMITEDBought 5,73,416 at ₹1,071.88Sold 5,73,716 at ₹1,073.420.89% of the companyNet −300 shares₹61 Cr bought
- Both waysPURE BROKING PRIVATE LIMITEDBought 6,28,198 at ₹1,049.01Sold 6,27,323 at ₹1,049.440.98% of the companyNet +875 shares₹66 Cr bought
- Both waysMICROCURVES TRADING PRIVATE LIMITEDBought 6,67,966 at ₹1,104.29Sold 6,67,966 at ₹1,105.171.04% of the companyNet nil₹74 Cr bought
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 8,42,160 at ₹1,063.42Sold 8,42,160 at ₹1,063.881.31% of the companyNet nil₹90 Cr bought
- Both waysGRT STRATEGIC VENTURES LLPBought 4,03,571 at ₹1,069.13Sold 4,03,571 at ₹1,069.400.63% of the companyNet nil₹43 Cr bought
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 23 deals on record since listing on 1 Sep 2026.